As the pharma industry awaits Congressional action on the bill, gaping holes in the domestic drug manufacturing ecosystem have never been clearer.
As the pharma industry awaits Congressional action on the bill, gaping holes in the domestic drug manufacturing ecosystem have never been clearer.